Calico Life Sciences LLC is a research and development organization formed under Alphabet Inc., dedicated to advancing our understanding of the biology of human aging. Through the integration of cutting-edge technologies and model systems, Calico seeks to uncover the fundamental mechanisms that control aging and devise interventions aimed at promoting longer, healthier lives. Their commitment to curiosity-driven discovery science fosters collaboration with academic and industry partners, creating a vibrant drug development pipeline. The organization prides itself on nurturing an innovative research environment where groundbreaking medical breakthroughs can thrive, driven by a team of talented scientists dedicated to addressing age-related diseases and improving overall health outcomes.